The invention relates to 6-substituted isoquinoline and isoquinolinonederivatives of the formula (I) useful for thetreatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin lightchain phosphatase, and compositions containing such compounds.